TY  - JOUR
AU  - Serrano-Castro, P J
AU  - Estivill-Torrús, G
AU  - Cabezudo-García, P
AU  - Reyes-Bueno, J A
AU  - Ciano Petersen, N
AU  - Aguilar-Castillo, M J
AU  - Suárez-Pérez, J
AU  - Jiménez-Hernández, M D
AU  - Moya-Molina, M Á
AU  - Oliver-Martos, B
AU  - Arrabal-Gómez, C
AU  - Rodríguez de Fonseca, F
PY  - 2020
DO  - 10.1016/j.nrl.2020.04.002
UR  - https://hdl.handle.net/10668/24587
T2  - Neurologia
AB  - SARS-CoV-2 was first detected in December 2019 in the Chinese city of Wuhan and has since spread across the world. At present, the virus has infected over 1.7 million people and caused over 100 000 deaths worldwide. Research is currently focused on...
LA  - en
KW  - COVID-19
KW  - Cytokine storm
KW  - Enfermedades neurodegenerativas
KW  - Enfermedades neuropsiquiátricas
KW  - Neurodegenerative diseases
KW  - Neuroinflamación
KW  - Neuroinflammation
KW  - Neuropsychiatric diseases
KW  - SARS-CoV-2
KW  - Tormenta de citoquinas
KW  - Betacoronavirus
KW  - COVID-19
KW  - Coronavirus Infections
KW  - Cytokine Release Syndrome
KW  - Cytokines
KW  - Disease Progression
KW  - Humans
KW  - Immune System
KW  - Inflammation
KW  - Inflammation Mediators
KW  - Mental Disorders
KW  - Models, Immunological
KW  - Models, Neurological
KW  - Neurodegenerative Diseases
KW  - Neuroimmunomodulation
KW  - Pandemics
KW  - Pneumonia, Viral
KW  - Public Health
KW  - SARS-CoV-2
KW  - Time Factors
TI  - Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
T2  - Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada?
TY  - research article
VL  - 35
ER  -